CYP2C9*3 gene variant contributes independently to glycaemic control in patients with type 2 diabetes treated with glibenclamide-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CYP2C9*3 gene variant contributes independently to glycaemic control in patients with type 2 diabetes treated with glibenclamide

Published:2018-05-26 Issue:6 Volume:43 Page:768-774
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Castelán-Martínez O. D.¹^ORCID,Hoyo-Vadillo C.²,Bazán-Soto T. B.¹,Cruz M.³,Tesoro-Cruz E.⁴,Valladares-Salgado A.³

Affiliation:

1. Facultad de Estudios Superiores Zaragoza; Universidad Nacional Autónoma de México; Mexico City Mexico

2. Departamento de Farmacología; Centro de Investigación y Estudios Avanzados del IPN; Mexico City Mexico

3. Unidad de Investigación Médica en Bioquímica; Centro Médico Nacional Siglo XXI IMSS; Mexico City Mexico

4. Unidad de Investigación Médica en Inmunología e Infectología; Centro Médico Nacional La Raza; Mexico City Mexico

Funder

Pharmacology Department

Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcpt.12710/fullpdf

Reference36 articles.

1. Global estimates of diabetes prevalence for 2013 and projections for 2035;Guariguata;Diabetes Res Clin Pract,2014

2. Is glucose control important for prevention of cardiovascular disease in diabetes?;Mannucci;Diabetes Care,2013

3. Chronic hyperglycemia and glucose toxicity: pathology and clinical sequelae;Campos;Postgrad Med,2012

4. Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis;Hirst;Diabetologia,2013

5. Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications;Desai;Am J Med,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics: The roles of genetic factors on treatment response and outcomes in diabetes;Internet of Things and Machine Learning for Type I and Type II Diabetes;2024

2. From Pharmacogenetics to Gene Expression: Implications for Precision Medicine in Diabetes;Drug Metabolism;2021-12-22

3. Pharmacogenomics of sulfonylureas in type 2 diabetes mellitus; a systematic review;Journal of Diabetes & Metabolic Disorders;2021-12-01

4. A pharmacogenetic pilot study of CYP2C9 common genetic variant and sulfonylureas therapeutic response in type 2 diabetes mellitus patients;Journal of Diabetes & Metabolic Disorders;2021-09-14

5. Current progress in pharmacogenomics of Type 2 diabetes: A systemic overview;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2021-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3